IMMUNOHEMATOLOGY - RED BLOOD CELL REAGENTS/ENZYME-TREATED RED BLOOD CELL REAGENTS - ANVISA Registration 80134860291

Access comprehensive regulatory information for IMMUNOHEMATOLOGY - RED BLOOD CELL REAGENTS/ENZYME-TREATED RED BLOOD CELL REAGENTS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80134860291 and manufactured by MEDION DIAGNOSTICS GRIFOLS AG. The registration is held by GRIFOLS BRASIL LTDA with validity until Jun 26, 2033.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including IMMUCOR, INC, MEDION DIAGNOSTICS GRIFOLS AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80134860291
2 Related Devices
Registration Details
ANVISA Registration Number: 80134860291
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

80134860291

25351395214202218

02513899000171

Company Information

Switzerland
PT: SUÍÇA

Dates and Status

Jun 26, 2023

26/06/2033

09/18/2025 19:00:01

Registration Details

80134860291

25351395214202218

02513899000171

Company Information

Dates and Status

Jun 26, 2023

26/06/2033

09/18/2025 19:00:01